![生物技术行业——利用我们在成像技术方面的专业知识和能力,推动您在生命科学技术发展领域的创新。 生物技术行业——利用我们在成像技术方面的专业知识和能力,推动您在生命科学技术发展领域的创新。]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original.image_file.100.56.file/zeiss-biotech-solutions.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original.image_file.360.203.file/zeiss-biotech-solutions.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original.image_file.768.432.file/zeiss-biotech-solutions.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original.image_file.1024.576.file/zeiss-biotech-solutions.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original.image_file.1280.720.file/zeiss-biotech-solutions.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original.image_file.1440.810.file/zeiss-biotech-solutions.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-biotech-solutions.jpg/_jcr_content/renditions/original./zeiss-biotech-solutions.jpg"})
行业解决方案
生物技术工具 促进下一代研究和医疗保健
![新型冠状病毒,使用蔡司GeminiSEM 560成像。由英国英格兰公共卫生局病毒参考部门的M. Hannah提供。 新型冠状病毒,使用蔡司GeminiSEM 560成像。由英国英格兰公共卫生局病毒参考部门的M. Hannah提供。]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.100.56.0,0,1917,1080.file/brightfield_covid-19_purple.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.360.203.0,0,1917,1080.file/brightfield_covid-19_purple.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.768.432.0,0,1917,1080.file/brightfield_covid-19_purple.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1024.576.0,0,1917,1080.file/brightfield_covid-19_purple.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1280.720.0,0,1917,1080.file/brightfield_covid-19_purple.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1440.810.0,0,1917,1080.file/brightfield_covid-19_purple.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1917.1078.0,0,1917,1080.file/brightfield_covid-19_purple.jpg"})
![新型冠状病毒,使用蔡司GeminiSEM 560成像。由英国英格兰公共卫生局病毒参考部门的M. Hannah提供。 新型冠状病毒,使用蔡司GeminiSEM 560成像。由英国英格兰公共卫生局病毒参考部门的M. Hannah提供。]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.100.56.file/brightfield_covid-19_purple.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.360.203.file/brightfield_covid-19_purple.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.768.432.file/brightfield_covid-19_purple.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1024.576.file/brightfield_covid-19_purple.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1280.720.file/brightfield_covid-19_purple.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original.image_file.1440.810.file/brightfield_covid-19_purple.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/brightfield_covid-19_purple.jpg/_jcr_content/renditions/original./brightfield_covid-19_purple.jpg"})
新型冠状病毒,使用蔡司GeminiSEM 560成像。由英国英格兰公共卫生局病毒参考部门的M. Hannah提供。
新型冠状病毒,使用蔡司GeminiSEM 560成像。由英国英格兰公共卫生局病毒参考部门的M. Hannah提供。
生命科学研究
从各个层面来看,就革命性生物技术工具的开发和应用而言,生命科学研究都将是关键。从了解三维细胞生物学以揭示器官芯片平台的开发路线图,到验证并改进空间组学工作流,再到无数其他生命科学研究挑战,都需要我们逐一攻克。
生物技术工具
![蔡司OEM 蔡司OEM]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.100.100.356,0,1636,1280.file/objectives-top-view.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.360.360.356,0,1636,1280.file/objectives-top-view.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.768.768.356,0,1636,1280.file/objectives-top-view.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.1024.1024.356,0,1636,1280.file/objectives-top-view.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.1280.1280.356,0,1636,1280.file/objectives-top-view.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.1280.1280.356,0,1636,1280.file/objectives-top-view.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/objectives-top-view.jpg/_jcr_content/renditions/original.image_file.1280.1280.356,0,1636,1280.file/objectives-top-view.jpg"})
蔡司OEM——使用蔡司技术提升您的产品
在您的产品中使用蔡司OEM显微镜或零件,或成为增值经销商(VAR)。
![蔡司Solutions Lab 蔡司Solutions Lab]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.100.100.828,12,2094,1278.file/solution-lab-wallpaper.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.360.360.828,12,2094,1278.file/solution-lab-wallpaper.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.768.768.828,12,2094,1278.file/solution-lab-wallpaper.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.1024.1024.828,12,2094,1278.file/solution-lab-wallpaper.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.1266.1266.828,12,2094,1278.file/solution-lab-wallpaper.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.1266.1266.828,12,2094,1278.file/solution-lab-wallpaper.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/products/software/zeiss-solutionslab/solution-lab-wallpaper.jpg/_jcr_content/renditions/original.image_file.1266.1266.828,12,2094,1278.file/solution-lab-wallpaper.jpg"})
蔡司Solutions Lab——从快速应用开发中获益
利用软件定制以改进工作流、实现自动化分析并缩短获取结果的时间。
![蔡司风险投资 蔡司风险投资]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.100.100.457,0,1537,1080.file/zeiss-ventures.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.360.360.457,0,1537,1080.file/zeiss-ventures.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.768.768.457,0,1537,1080.file/zeiss-ventures.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.1024.1024.457,0,1537,1080.file/zeiss-ventures.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.1080.1080.457,0,1537,1080.file/zeiss-ventures.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.1080.1080.457,0,1537,1080.file/zeiss-ventures.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/applications/life-sciences/pharmaceutical-biotech-industry/zeiss-ventures.jpg/_jcr_content/renditions/original.image_file.1080.1080.457,0,1537,1080.file/zeiss-ventures.jpg"})
蔡司风险投资——强大的战略风险投资合作伙伴
帮助生物技术初创公司塑造市场。